Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novavax reported $-293905000 in Net Income for its fiscal quarter ending in March of 2023.

Net Income Change
Agenus AGEN:US USD -68254000 2.84M
AstraZeneca AZN:LN USD 1.8B 902M
BioCryst Pharmaceuticals BCRX:US USD -53333000 18.21M
Geron GERN:US USD -38122000 4.51M
GlaxoSmithKline GSK:LN GBP 1.49B 5M
MannKind MNKD:US USD -9795000 8.15M
Merck & Co MRK:US USD 2.82B 196M
Minerva Neurosciences NERV:US USD -6970000 244K
Moderna Inc MRNA:US USD 79M 1.39B
Novartis NVS:US USD 2.29B 827M
Novavax NVAX:US USD -293905000 111.66M
Peregrine Pharmaceuticals PPHM:US USD 461K 1.62M
Pfizer PFE:US USD 5.54B 548M
Sarepta Therapeutics SRPT:US USD -516755000 407.51M
TG Therapeutics TGTX:US USD -39232000 13.76M